ANSWER AND REASONINGC. Plan treatment in a skull-base MDT, weighing observation, radiotherapy and surgery including vascular risk
Age, growth, cranial-nerve function, secretory status and carotid involvement determine management. Preoperative embolisation may help selected tumours but is not a substitute for a complete strategy.
Why every option is right or wrong
A. Biopsy the mass transorally without vascular imaging: Unplanned biopsy can cause major haemorrhage.
B. Operate on every tumour immediately: Observation or radiotherapy may better preserve function in selected patients.
C. Plan treatment in a skull-base MDT, weighing observation, radiotherapy and surgery including vascular risk: Age, growth, cranial-nerve function, secretory status and carotid involvement determine management. Preoperative embolisation may help selected tumours but is not a substitute for a complete strategy.
D. Ignore catecholamine symptoms: Secretory tumours require biochemical and anaesthetic planning.
E. Sacrifice the carotid without collateral-flow assessment: This creates avoidable stroke risk.
What if the scenario changed?
If biochemical testing showed catecholamine secretion, alpha blockade would be required before invasive treatment.
EDUCATIONAL USEIndependent Clinora educational preparation material; not official JCIE content, an accredited programme, clinical advice, or a substitute for current guidance, local policy and specialist judgement.
Back to the Section 1 bank